Synthetic binding agents for limiting permeation through mucus

JP2025170257APending Publication Date: 2025-11-18THE UNIV OF NORTH CAROLINA AT CHAPEL HILL +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2025126366
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-09-23
Filing Date
2025-07-29
Publication Date
2025-11-18

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

To provide methods and compositions (including compositions of engineered / synthetic binding agents) for enhancing agglutination, enchainment and / or muco-trapping of a target, i.e., reducing the fraction of target entities that could permeate through mucus, including pathogens and sperm.SOLUTION: Provided are synthetic binding agents for reducing the fraction of targets that can permeate through mucus and / or freely divide, and methods of reducing mucosal permeation and / or free division of a target using these synthetic binding agents. The synthetic binding agent comprises a human or humanized Immunoglobulin G (IgG) having a pair of Fab domains, and enhances agglutination of the target in the subject's mucus to reduce the mobility of the target to less than about 50% relative to its native mobility in mucus.SELECTED DRAWING: Figure 1A
Need to check novelty before this filing date? Find Prior Art